Bellevue Life Sciences Ac... (BLAC)
3.01
-3.72 (-55.27%)
At close: Feb 14, 2025, 3:53 PM
undefined% (undefined)
| Bid | 2.79 |
| Market Cap | 6.98M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.09 |
| PE Ratio (ttm) | -33.44 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 2.8 |
| Volume | 430,774 |
| Avg. Volume (20D) | 15,552 |
| Open | 3.89 |
| Previous Close | 6.73 |
| Day's Range | 3.01 - 4.43 |
| 52-Week Range | 3.01 - 13.40 |
| Beta | undefined |
About BLAC
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as...
Industry Shell Companies
Sector Financial Services
IPO Date Mar 21, 2023
Employees NaN
Stock Exchange NASDAQ
Ticker Symbol BLAC
1 week ago
+14.63%
Bellevue Life Sciences shares are trading lower. T...
Unlock content with
Pro Subscription